Login / Signup

Effectiveness of mRNA Vaccine Booster against SARS-CoV-2 Infection and COVID-19 in the Adult Population during the First Three Months of the Omicron Wave in Sicily.

Giuseppe VellaDario GenoveseMiriam BelluzzoLuca MazzeoVincenzo PisciottaEmanuele Amodio
Published in: Healthcare (Basel, Switzerland) (2023)
This study confirmed the remarkable efficacy profile of the SARS-CoV-2 vaccine booster dose against infection, severe disease, and death attributable to the virus. Overall, the results of this study provide important real-world data to support the continued roll-out of the COVID-19 booster dose and have the potential to inform public health policy and guide decisions on vaccination strategies in countries around the world.
Keyphrases
  • sars cov
  • public health
  • coronavirus disease
  • respiratory syndrome coronavirus
  • healthcare
  • randomized controlled trial
  • systematic review
  • risk assessment
  • electronic health record
  • data analysis
  • binding protein